• SPX
  • $5,973.10
  • 0.74 %
  • $44.06
  • DJI
  • $43,729.34
  • -0 %
  • -$0.59
  • N225
  • $39,381.41
  • -0.25 %
  • -$99.26
  • FTSE
  • $8,140.74
  • -0.32 %
  • -$25.94
  • IXIC
  • $19,269.46
  • 1.51 %
  • $285.99
GE HealthCare Technologies Inc. (GEHC) Stock Price, News & Analysis

GE HealthCare Technologies Inc. (GEHC) Stock Price, News & Analysis

Currency in USD Disclaimer

$88.23

$1.45

(1.67%)

Day's range
$86.94
Day's range
$88.88
50-day range
$83.14
Day's range
$94.55
  • Country: US
  • ISIN: US36266G1076
52 wk range
$66.39
Day's range
$94.55


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score 1.98
  • Piotroski Score 6.00
  • Grade Overweight
  • Symbol (GEHC)
  • Company GE HealthCare Technologies Inc.
  • Price $88.23
  • Changes Percentage (1.67%)
  • Change $1.45
  • Day Low $86.94
  • Day High $88.88
  • Year High $94.55

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, Hong Kong, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, and X-ray systems, as well as women's health products. The Ultrasound segment provides screening, diagnosis, treatment, and monitoring of certain diseases through radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment involved in the provision of medical devices, consumable products, services, and digital solutions through patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal infant care products. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals, administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents, or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes that are injected into a patient prior to a diagnostic imaging scan. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.

  • Last Earnings 09/18/2024
  • Ex-Dividend for 5/16 Dividend 10/18/2024
  • Dividend Payable 11/15/2024
  • Today N/A
  • Next Earnings (Estimated) 02/03/2025
  • Fiscal Year End N/A

  • Average Stock Price Target $96.50
  • High Stock Price Target $110.00
  • Low Stock Price Target $74.00
  • Potential Upside/Downside N/A
  • Consensus Rating Neutral
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) $3.44
  • Trailing P/E Ratio 22.19
  • Forward P/E Ratio 22.19
  • P/E Growth 22.19
  • Net Income $1.57 B

Income Statement

Quarterly

Annual

Latest News of GEHC

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.